HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tjun Yip Tang Selected Research

Cyanoacrylates

1/2022Pain Outcomes Following Mechanochemical Ablation vs Cyanoacrylate Adhesive for the Treatment of Primary Truncal Saphenous Vein Incompetence: The MOCCA Randomized Clinical Trial.
1/2021Endovenous cyanoacrylate ablation for chronic venous insufficiency and varicose veins among Asians.
1/2021Early results of an Asian prospective multicenter VenaSeal real-world postmarket evaluation to investigate the efficacy and safety of cyanoacrylate endovenous ablation for varicose veins.
12/2020Exit site complications following cyanoacrylate glue endovenous ablation of incompetent truncal veins for chronic venous insufficiency.
11/2020The utility of endovenous cyanoacrylate glue ablation for incompetent saphenous veins in the setting of venous leg ulcers.
8/2018Mechanochemical ablation versus cyanoacrylate adhesive for the treatment of varicose veins: study protocol for a randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tjun Yip Tang Research Topics

Disease

7Pathologic Constriction (Stenosis)
08/2022 - 07/2019
4Wounds and Injuries (Trauma)
01/2022 - 12/2020
4Chronic Limb-Threatening Ischemia
01/2022 - 11/2020
4Fistula
09/2021 - 07/2019
3Peripheral Arterial Disease
01/2022 - 11/2020
3Thrombosis (Thrombus)
07/2021 - 01/2018
3Chronic Kidney Failure (Chronic Renal Failure)
05/2021 - 12/2020
3Varicose Veins (Varicose Vein)
01/2021 - 08/2018
2Arteriovenous Fistula
01/2022 - 09/2019
2Frailty
01/2022 - 11/2020
2Hyperplasia
07/2021 - 07/2020
2Venous Insufficiency
01/2021 - 12/2020
1Peripheral Arterial Occlusive Disease 1
10/2022
1Pain (Aches)
01/2022
1Psoas Abscess
01/2022
1Endoleak
12/2021
1Foot Ulcer
11/2021
1Ulcer
11/2021
1Diabetic Foot
11/2021
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
04/2021
1Hypertension (High Blood Pressure)
01/2021
1Vascular Diseases (Vascular Disease)
12/2020
1Hypersensitivity (Allergy)
12/2020
1Granuloma
12/2020
1Infections
12/2020
1Sepsis (Septicemia)
11/2020
1Leg Ulcer
11/2020
1Hypotension (Low Blood Pressure)
09/2019
1Hypoglycemia (Reactive Hypoglycemia)
09/2019
1Diabetes Mellitus
09/2019
1Body Weight (Weight, Body)
09/2019
1Atherosclerosis
09/2019
1Renal Insufficiency (Renal Failure)
09/2019
1Varicose Ulcer (Ulcer, Venous)
12/2018

Drug/Important Bio-Agent (IBA)

6CyanoacrylatesIBA
01/2022 - 08/2018
4Sirolimus (Rapamycin)FDA Link
10/2022 - 07/2020
3Pharmaceutical PreparationsIBA
09/2021 - 09/2019
2Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 07/2021
2Oxygen (Dioxygen)IBA
11/2021 - 06/2021
1Hemoglobins (Hemoglobin)IBA
06/2021
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021
1ArgonIBA
12/2020
1Biological ProductsIBA
07/2020
1Lipoproteins (Lipoprotein)IBA
09/2019
1oxidized low density lipoproteinIBA
09/2019
1MetalsIBA
07/2019
1mesoglycanIBA
07/2019
1Ortho Evra (Evra)FDA Link
12/2018

Therapy/Procedure

5Stents
08/2022 - 07/2019
5Therapeutics
01/2022 - 12/2020
5Renal Dialysis (Hemodialysis)
12/2021 - 07/2019
4Surgical Amputation (Amputations)
01/2022 - 09/2019
2Debridement
06/2021 - 12/2020
1Length of Stay
01/2022
1Aftercare (After-Treatment)
12/2021
1Thrombectomy
04/2021
1Limb Salvage
12/2020
1Punctures
12/2020
1Patient Readmission
11/2020
1Glycemic Control
09/2019
1Laser Therapy (Surgery, Laser)
01/2018